fbpx

QQQ
+ 0.35
372.63
+ 0.09%
BTC/USD
-216.58
42593.99
-0.51%
DIA
+ 0.36
347.20
+ 0.1%
SPY
+ 0.78
442.40
+ 0.18%
TLT
-1.45
149.81
-0.98%
GLD
-0.19
163.70
-0.12%

Thinking About Buying Stock Or Options In Tilray, Ocugen, Biogen Or Snowflake?

June 11, 2021 8:20 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Thinking About Buying Stock Or Options In Tilray, Ocugen, Biogen Or Snowflake?

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Here are the latest analyst ratings and news updates for Tilray, Ocugen, Biogen and Snowflake.

CIBC analyst John Zamparo downgraded Tilray Inc (NASDAQ:TLRY) from Outperform to Neutral and announced a $25 price target.

HC Wainwright & Co. analyst Swayampakula Ramakanth maintained Ocugen Inc (NASDAQ:OCGN) with a Buy and lowered the price target from $12 to $10.

Roth Capital analyst Zegbeh Jallah downgraded Ocugen from Buy to Neutral and lowered the price target from $10 to $6.

Bernstein analyst Aaron Gal upgraded Biogen Inc (NASDAQ:BIIB) from Market Perform to Outperform and announced a $500 price target.

Rosenblatt analyst Blair Abernethy maintained Snowflake Inc (NYSE:SNOW) with a Buy and lowered the price target from $270 to $265.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Why Biogen Shares Are Trading Higher Today

Biogen Inc (NASDAQ: BIIB) shares are trading higher by 3.2% at $419.81 after SVB Leerink maintained an Outperform on the stock and raised its price target from $380 to $475. read more

Thinking About Buying Stock Or Options In Target, Biogen Or Delta Air Lines?

One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving. read more
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More

Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More

Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included picks from Gene Munster and the maker of a potentially blockbuster Alzheimer's treatment. read more
Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2

Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2

Warren Buffett-led Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) sharply lowered its exposure in General Motors Co (NYSE: read more